Search

Angela A. Armstrong

Examiner (ID: 7226, Phone: (571)272-7598 , Office: P/2659 )

Most Active Art Unit
2659
Art Unit(s)
2659, 2641, 2741, 2654, 2626
Total Applications
1003
Issued Applications
675
Pending Applications
123
Abandoned Applications
230

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 225063 [patent_doc_number] => 07605247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-10-20 [patent_title] => 'Nucleic acid molecules encoding a wheat sucrose transporter' [patent_app_type] => utility [patent_app_number] => 11/901765 [patent_app_country] => US [patent_app_date] => 2007-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11183 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/605/07605247.pdf [firstpage_image] =>[orig_patent_app_number] => 11901765 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/901765
Nucleic acid molecules encoding a wheat sucrose transporter Sep 17, 2007 Issued
Array ( [id] => 4807750 [patent_doc_number] => 20080171328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Screening assays for hedgehog agonists and antagonists' [patent_app_type] => utility [patent_app_number] => 11/894601 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 75590 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171328.pdf [firstpage_image] =>[orig_patent_app_number] => 11894601 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/894601
Screening assays for hedgehog agonists and antagonists Aug 19, 2007 Abandoned
Array ( [id] => 5338168 [patent_doc_number] => 20090054632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Hydrophobically-modified protein compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/894745 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 33608 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054632.pdf [firstpage_image] =>[orig_patent_app_number] => 11894745 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/894745
Hydrophobically-modified protein compositions and methods Aug 19, 2007 Abandoned
Array ( [id] => 4697865 [patent_doc_number] => 20080220049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins' [patent_app_type] => utility [patent_app_number] => 11/894045 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 44316 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220049.pdf [firstpage_image] =>[orig_patent_app_number] => 11894045 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/894045
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins Aug 16, 2007 Abandoned
Array ( [id] => 8555165 [patent_doc_number] => 08329637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Method for the treatment of automimmune diseases comprising administering rapamycin and IL-10' [patent_app_type] => utility [patent_app_number] => 11/839676 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8100 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11839676 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/839676
Method for the treatment of automimmune diseases comprising administering rapamycin and IL-10 Aug 15, 2007 Issued
Array ( [id] => 6025793 [patent_doc_number] => 20110053849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'REGULATION OF LITAF MODULATED CYTOKINE PRODUCTION BY A NOVEL P53 SHORT PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/377545 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8199 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053849.pdf [firstpage_image] =>[orig_patent_app_number] => 12377545 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/377545
REGULATION OF LITAF MODULATED CYTOKINE PRODUCTION BY A NOVEL P53 SHORT PEPTIDE Aug 8, 2007 Abandoned
Array ( [id] => 5392156 [patent_doc_number] => 20090209469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Use of Exendins and GLP-1 Receptor Agonists for Altering Lipoprotein Particle Size and Subclass Composition' [patent_app_type] => utility [patent_app_number] => 12/374569 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37252 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209469.pdf [firstpage_image] =>[orig_patent_app_number] => 12374569 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/374569
Use of Exendins and GLP-1 Receptor Agonists for Altering Lipoprotein Particle Size and Subclass Composition Aug 5, 2007 Abandoned
Array ( [id] => 4905824 [patent_doc_number] => 20080115238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'HEDGEHOG INHIBITOR ASSAY' [patent_app_type] => utility [patent_app_number] => 11/828406 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16647 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20080115238.pdf [firstpage_image] =>[orig_patent_app_number] => 11828406 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/828406
HEDGEHOG INHIBITOR ASSAY Jul 25, 2007 Abandoned
Array ( [id] => 8549277 [patent_doc_number] => 08324158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Methods for inhibiting CLC-2 channel with GATX2' [patent_app_type] => utility [patent_app_number] => 12/373556 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 22 [patent_no_of_words] => 24399 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373556 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/373556
Methods for inhibiting CLC-2 channel with GATX2 Jul 11, 2007 Issued
Array ( [id] => 5046515 [patent_doc_number] => 20070265189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/775642 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 123 [patent_figures_cnt] => 123 [patent_no_of_words] => 48577 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265189.pdf [firstpage_image] =>[orig_patent_app_number] => 11775642 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/775642
INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS Jul 9, 2007 Abandoned
Array ( [id] => 5271094 [patent_doc_number] => 20090074870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Alteration of cell membrane for new functions' [patent_app_type] => utility [patent_app_number] => 11/819080 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9231 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074870.pdf [firstpage_image] =>[orig_patent_app_number] => 11819080 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/819080
Alteration of cell membrane with FasL Jun 24, 2007 Issued
Array ( [id] => 6219997 [patent_doc_number] => 20100055092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Preventive or Remedy for Inflammatory Disease' [patent_app_type] => utility [patent_app_number] => 12/303684 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12858 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055092.pdf [firstpage_image] =>[orig_patent_app_number] => 12303684 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/303684
Method of treating an inflammatory disease comprising administering an NR 10 antibody antagonist Jun 7, 2007 Issued
Array ( [id] => 123481 [patent_doc_number] => 07705119 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-04-27 [patent_title] => 'Compositions and methods useful for treating circulatory and hypovolemic shock' [patent_app_type] => utility [patent_app_number] => 11/759013 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13483 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705119.pdf [firstpage_image] =>[orig_patent_app_number] => 11759013 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/759013
Compositions and methods useful for treating circulatory and hypovolemic shock Jun 5, 2007 Issued
Array ( [id] => 8146692 [patent_doc_number] => 08163699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Method for the treatment of valvular disease' [patent_app_type] => utility [patent_app_number] => 12/227872 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10167 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163699.pdf [firstpage_image] =>[orig_patent_app_number] => 12227872 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/227872
Method for the treatment of valvular disease May 22, 2007 Issued
Array ( [id] => 4899310 [patent_doc_number] => 20080118924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'USE OF NATRIURETIC PEPTIDES AS DIAGNOSTIC AND PROGNOSTIC INDICATORS IN VASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 11/752135 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17753 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118924.pdf [firstpage_image] =>[orig_patent_app_number] => 11752135 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/752135
USE OF NATRIURETIC PEPTIDES AS DIAGNOSTIC AND PROGNOSTIC INDICATORS IN VASCULAR DISEASES May 21, 2007 Abandoned
Array ( [id] => 7740550 [patent_doc_number] => 08106013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'ABC transporter ligand GATX1' [patent_app_type] => utility [patent_app_number] => 12/299881 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 26790 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106013.pdf [firstpage_image] =>[orig_patent_app_number] => 12299881 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/299881
ABC transporter ligand GATX1 May 17, 2007 Issued
Array ( [id] => 7509850 [patent_doc_number] => 20110256091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Antibody-Targeted Cytokines for Therapy' [patent_app_type] => utility [patent_app_number] => 12/227060 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10053 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256091.pdf [firstpage_image] =>[orig_patent_app_number] => 12227060 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/227060
Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritis May 7, 2007 Issued
Array ( [id] => 4693091 [patent_doc_number] => 20080085862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'NATRIURETIC PEPTIDE CONJUGATE USING CARRIER SUBSTANCE' [patent_app_type] => utility [patent_app_number] => 11/744162 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5772 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085862.pdf [firstpage_image] =>[orig_patent_app_number] => 11744162 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/744162
NATRIURETIC PEPTIDE CONJUGATE USING CARRIER SUBSTANCE May 2, 2007 Abandoned
Array ( [id] => 5374676 [patent_doc_number] => 20090312237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'REGULATING FAT AND CARBOHYDRATE OXIDATION IN MUSCLE TISSUE COMPRISING CONTROLLING GARNITINE CONTENT IN MUSCLE' [patent_app_type] => utility [patent_app_number] => 12/295973 [patent_app_country] => US [patent_app_date] => 2007-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4977 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312237.pdf [firstpage_image] =>[orig_patent_app_number] => 12295973 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/295973
REGULATING FAT AND CARBOHYDRATE OXIDATION IN MUSCLE TISSUE COMPRISING CONTROLLING GARNITINE CONTENT IN MUSCLE Apr 1, 2007 Abandoned
Array ( [id] => 5397770 [patent_doc_number] => 20090317833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Screening Method' [patent_app_type] => utility [patent_app_number] => 12/225721 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19994 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317833.pdf [firstpage_image] =>[orig_patent_app_number] => 12225721 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225721
Screening method for a substance that binds to an intracellular region of TLR4 Mar 28, 2007 Issued
Menu